These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4502570)

  • 1. Central nervous system involvement in leukaemia.
    Neville BG
    Dev Med Child Neurol; 1972 Feb; 14(1):75-8. PubMed ID: 4502570
    [No Abstract]   [Full Text] [Related]  

  • 2. Encephalopathy in acute leukaemia associated with methotrexate therapy.
    Kay HE; Knapton PJ; O'Sullivan JP; Wells DG; Harris RF; Innes EM; Stuart J; Schwartz FC; Thompson EN
    Arch Dis Child; 1972 Jun; 47(253):344-54. PubMed ID: 4504035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disseminated necrotizing leukoencephalopathy following intrathecal methotrexate in childhood leukemia (author's transl)].
    Koga S; Fujimoto T; Hasegawa K; Sueishi K
    Fukuoka Igaku Zasshi; 1976 Jan; 67(1):24-31. PubMed ID: 1062350
    [No Abstract]   [Full Text] [Related]  

  • 4. Submicroscopic changes in leukaemia cells of the cerebrospinal fluid following intrathecal methotrexate.
    Péter A
    Acta Neuropathol; 1974; 29(4):345-54. PubMed ID: 4531812
    [No Abstract]   [Full Text] [Related]  

  • 5. Cerebral calcifications associated with intrathecal methotrexate therapy in acute lymphocytic leukemia.
    Garwicz S; Mortensson W
    J Pediatr; 1977 Mar; 90(3):496-7. PubMed ID: 264958
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating the nervous system in acute leukaemia.
    Spiers AS; Firth JL; Collins CD
    Lancet; 1972 Feb; 1(7747):433-4. PubMed ID: 4110659
    [No Abstract]   [Full Text] [Related]  

  • 7. [Successful intrathecal treatment of meningeal leukaemia with methotrexate in the adult].
    Kölmel HW; Manke HG; Drings P; Dimou E; Kelleter R
    Dtsch Med Wochenschr; 1973 Feb; 98(6):259-61. PubMed ID: 4509816
    [No Abstract]   [Full Text] [Related]  

  • 8. Cerebral calcifications associated with intrathecal methotrexate therapy in acute lymphocytic leukemia.
    Mueller S; Bell W; Seibert J
    J Pediatr; 1976 Apr; 88(4 Pt 1):650-3. PubMed ID: 1062546
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic treatment of meningeal leukemia in children by intrathecal methotrexate.
    Wahidijat I; Markum AH; Abdulsalam M; Muslichan S; Odang O
    Acta Haematol; 1972; 47(2):81-8. PubMed ID: 4623363
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.
    Bleyer WA; Drake JC; Chabner BA
    N Engl J Med; 1973 Oct; 289(15):770-3. PubMed ID: 4517004
    [No Abstract]   [Full Text] [Related]  

  • 11. Recovery of meningeal leukaemia. A case report.
    Schaafsma S
    Eur Neurol; 1972; 7(3):189-95. PubMed ID: 4503310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prophylactic central nervous system therapy in childhood leukemia and its complications].
    Tsukimoto I
    Rinsho Ketsueki; 1988 Apr; 29(4):449-56. PubMed ID: 3165476
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute encephalopathy after initiation of cranial irradiation for meningeal leukaemia.
    Castells-van Daele M; van de Casseye W
    Lancet; 1978 Oct; 2(8094):834-5. PubMed ID: 81379
    [No Abstract]   [Full Text] [Related]  

  • 14. [Intrathecal methotrexate--overdosing in pediatric lymphoblastic leukemia].
    Reddemann H; Schwesinger G; Riethdorf L
    Psychiatr Neurol Med Psychol (Leipz); 1987 Jun; 39(6):365-71. PubMed ID: 3477827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Leukemic meningeal involvement in adults and its treatment].
    Lawińska B; Krzysztoń Z; Pawlak L; Podolak-Dawidziak M; Tychowski K
    Neurol Neurochir Pol; 1977; 11(3):361-5. PubMed ID: 267811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Leukaemia of the central nervous system.
    Reske-Nielsen E; Petersen JH; Sogaard H; Jensen KB
    Lancet; 1974 Feb; 1(7850):211-2. PubMed ID: 4129892
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic methotrexate toxicity to the central nervous system.
    Shapiro WR; Allen JC; Horten BC
    Clin Bull; 1980; 10(2):49-52. PubMed ID: 6893169
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrospective study and perspectives in the treatment of meningeal leukaemia.
    Fickers M; Haak HL; Speck B
    Folia Med Neerl; 1972; 15(6):271-5. PubMed ID: 4509018
    [No Abstract]   [Full Text] [Related]  

  • 19. Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia.
    Duttera MJ; Bleyer WA; Pomeroy TC; Leventhal CM; Leventhal BG
    Lancet; 1973 Sep; 2(7831):703-7. PubMed ID: 4125793
    [No Abstract]   [Full Text] [Related]  

  • 20. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.
    Moe PJ; Seip M; Finne PH
    Acta Paediatr Scand; 1981 Jan; 70(1):73-9. PubMed ID: 6971042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.